Chromatography Reagents Market: Size & Share Breakdown.
Meticulous Research® has recently published a...
Quris-AI Acquires Nortis to Improve Drug Safety Prediction
Quris-AI Acquires Nortis to Improve Drug Safety PredictionQuris-AI, a leading Bio-AI innovator disrupting the drug development process using advanced artificial intelligence models, has acquired Nortis to improve its platform’s ability to predict drug safety and efficacy in humans. The acquisition of the Brazil-based microphysiology systems (MPS) technology pioneer allows Quris-Ai to integrate Nortis’ Kidney-on-Chip technology into its Bio-AI platform, enhancing the company’s capability in helping pharmaceutical companies develop safe and effective medicines.
Please login to comment on this Post